Galli SJ, Gaudenzio N, Tsai M. Mast cells in inflammation and disease: recent progress and ongoing concerns. Annu Rev Immunol. 2020;38:49–77.
Article CAS PubMed Google Scholar
Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, et al. Mast cells and inflammation. Biochim Biophys Acta. 2012;1822:21–33.
Article CAS PubMed Google Scholar
Nautiyal KM, Dailey CA, Jahn JL, Rodriquez E, Son NH, Sweedler JV, et al. Serotonin of mast cell origin contributes to hippocampal function. Eur J Neurosci. 2012;36:2347–59.
Article PubMed PubMed Central Google Scholar
Porzionato A, Macchi V, Parenti A, De Caro R. The distribution of mast cells in the human area postrema. J Anat. 2004;204:141–7.
Article PubMed PubMed Central Google Scholar
Arac A, Grimbaldeston MA, Nepomuceno AR, Olayiwola O, Pereira MP, Nishiyama Y, et al. Evidence that meningeal mast cells can worsen stroke pathology in mice. Am J Pathol. 2014;184:2493–504.
Article CAS PubMed PubMed Central Google Scholar
Theoharides TC. The impact of psychological stress on mast cells. Ann Allergy Asthma Immunol. 2020;125:388–92.
Article CAS PubMed Google Scholar
Duque-Wilckens N, Teis R, Sarno E, Stoelting F, Khalid S, Dairi Z, et al. Early life adversity drives sex-specific anhedonia and meningeal immune gene expression through mast cell activation. Brain Behav Immun. 2022;103:73–84.
Article CAS PubMed PubMed Central Google Scholar
Hendriksen E, van Bergeijk D, Oosting RS, Redegeld FA. Mast cells in neuroinflammation and brain disorders. Neurosci Biobehav Rev. 2017;79:119–33.
Article CAS PubMed Google Scholar
Nicoloro SantaBarbara J, Lobel M. Depression, psychosocial correlates, and psychosocial resources in individuals with mast cell activation syndrome. J Health Psychol. 2022;27:2013–26.
Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, et al. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci. 2017;11:216.
Article PubMed PubMed Central Google Scholar
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234–56.
Article CAS PubMed PubMed Central Google Scholar
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, et al. Neuroinflammation and depression: a review. Eur J Neurosci. 2021;53:151–71.
Article CAS PubMed Google Scholar
Tanioka D, Chikahisa S, Shimizu N, Shiuchi T, Sakai N, Nishino S, et al. Intracranial mast cells contribute to the control of social behavior in male mice. Behav Brain Res. 2021;403:113143.
Article CAS PubMed Google Scholar
Ketabforoush A, Chegini R, Barati S, Tahmasebi F, Moghisseh B, Joghataei MT, et al. Masitinib: the promising actor in the next season of the amyotrophic lateral sclerosis treatment series. Biomed Pharmacother. 2023;160:114378.
Article CAS PubMed Google Scholar
Yuan HP, Li Z, Zhang Y, Li XP, Li FK, Li YQ. Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia. Int J Clin Exp Med. 2015;8:8010–4.
PubMed PubMed Central Google Scholar
Jia S, Yang H, Huang F, Fan W. Systemic inflammation, neuroinflammation and perioperative neurocognitive disorders. Inflamm Res. 2023;72:1895–907.
Article CAS PubMed Google Scholar
Wang Y, Sha H, Zhou L, Chen Y, Zhou Q, Dong H, et al. The mast cell is an early activator of lipopolysaccharide-induced neuroinflammation and blood–brain barrier dysfunction in the hippocampus. Mediators Inflamm. 2020;2020:8098439.
Article PubMed PubMed Central Google Scholar
Germundson DL, Nagamoto-Combs K. Potential role of intracranial mast cells in neuroinflammation and neuropathology associated with food allergy. Cells. 2022;11:738.
Article CAS PubMed PubMed Central Google Scholar
Georgin-Lavialle S, Moura DS, Salvador A, Chauvet-Gelinier JC, Launay JM, Damaj G, et al. Mast cells’ involvement in inflammation pathways linked to depression: evidence in mastocytosis. Mol Psychiatry. 2016;21:1511–6.
Article CAS PubMed Google Scholar
Fu S, Ni S, Wang D, Fu M, Hong T. Berberine suppresses mast cell-mediated allergic responses via regulating FcvarepsilonRI-mediated and MAPK signaling. Int Immunopharmacol. 2019;71:1–6.
Article CAS PubMed Google Scholar
Pan S, Zhao X, Ji N, Shao C, Fu B, Zhang Z, et al. Inhibitory effect of taxifolin on mast cell activation and mast cell-mediated allergic inflammatory response. Int Immunopharmacol. 2019;71:205–14.
Article CAS PubMed Google Scholar
Lee EJ, Ji GE, Sung MK. Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells. Inflamm Res. 2010;59:847–54.
Article CAS PubMed Google Scholar
Che DN, Shin JY, Kang HJ, Cho BO, Kim YS, Jang SI. Luteolin suppresses IL-31 production in IL-33-stimulated mast cells through MAPK and NF-kappaB signaling pathways. Int Immunopharmacol. 2020;83:106403.
Article CAS PubMed Google Scholar
Fu LX, Chen T, Sun QM, Zhou PM, Guo ZP. Interleukin-35 inhibited the production of histamine and pro-inflammatory cytokines through suppression MAPKs pathway in HMC-1 cells. Allergy Asthma Clin Immunol. 2021;17:38.
Article CAS PubMed PubMed Central Google Scholar
Nam SY, Han NR, Yoon KW, Kim HM, Jeong HJ. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), an anticancer agent, exerts an anti-inflammatory effect in activated human mast cells. Inflamm Res. 2017;66:871–9.
Article CAS PubMed Google Scholar
Min YD, Choi CH, Bark H, Son HY, Park HH, Lee S, et al. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res. 2007;56:210–5.
Article CAS PubMed Google Scholar
Zelechowska P, Agier J, Rozalska S, Wiktorska M, Brzezinska-Blaszczyk E. Leptin stimulates tissue rat mast cell pro-inflammatory activity and migratory response. Inflamm Res. 2018;67:789–99.
Article CAS PubMed PubMed Central Google Scholar
Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Tertilt C, Bopp T, et al. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J Immunol. 2006;177:6667–74.
Article CAS PubMed Google Scholar
Bacsa B, Graziani A, Krivic D, Wiedner P, Malli R, Rauter T, et al. Pharmaco-optogenetic targeting of TRPC activity allows for precise control over mast cell NFAT signaling. Front Immunol. 2020;11:613194.
Article CAS PubMed PubMed Central Google Scholar
Walczak-Drzewiecka A, Ratajewski M, Wagner W, Dastych J. HIF-1alpha is up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J Immunol. 2008;181:1665–72.
Article CAS PubMed Google Scholar
Chen YC, Chang YC, Chang HA, Lin YS, Tsao CW, Shen MR, et al. Differential Ca(2+) mobilization and mast cell degranulation by FcepsilonRI- and GPCR-mediated signaling. Cell Calcium. 2017;67:31–9.
Article CAS PubMed Google Scholar
Obeng B, Potts CM, West BE, Burnell JE, Fleming PJ, Shim JK, et al. Pharmaceutical agent cetylpyridinium chloride inhibits immune mast cell function by interfering with calcium mobilization. bioRxiv. 2023. https://doi.org/10.1101/2023.05.23.541979.
Article PubMed PubMed Central Google Scholar
Oh-hora M. Calcium signaling in the development and function of T-lineage cells. Immunol Rev. 2009;231:210–24.
Article CAS PubMed Google Scholar
Li Y, Sun X, Juan Z, Guan X, Wang M, Meng Y, et al. Propofol pretreatment alleviates mast cell degranulation by inhibiting SOC to protect the myocardium from ischemia-reperfusion injury. Biomed Pharmacother. 2022;150: 113014.
Article CAS PubMed Google Scholar
Chaki S, Alkanfari I, Roy S, Amponnawarat A, Hui Y, Oskeritzian CA, et al. Inhibition of orai channel function regulates mas-related G protein-coupled receptor-mediated responses in mast cells. Front Immunol. 2021;12:803335.
留言 (0)